Flatiron Data Supports Using Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer
- Women's Health
- 09/05/2022
This Pfizer-sponsored study used de-identified data derived from the Flatiron Health Analytic Database in a retrospective observational study to demonstrate palbociclib (PAL) combined with an aromata
READ MORE